Invesco Ltd. Increases Holdings in Aehr Test Systems $AEHR

Key Points

• Invesco Ltd. increased its stake in Aehr Test Systems by 88.8% in Q1, owning 30,226 shares valued at $220,000.
• Insider selling included VP Alistair N. Sporck, who sold 3,000 shares, and Director Laura Oliphant, who sold 5,000 shares, resulting in significant decreases in their ownership percentages.
• Aehr Test Systems reported an EPS of ($0.01) for the latest quarter, slightly beating estimates, and had revenue of $14.10 million, which fell short of analyst expectations.

Invesco Ltd. increased its position in shares of Aehr Test Systems (NASDAQ:AEHR - Free Report) by 88.8% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 30,226 shares of the semiconductor company's stock after acquiring an additional 14,219 shares during the period. Invesco Ltd. owned about 0.10% of Aehr Test Systems worth $220,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in AEHR. Raymond James Financial Inc. bought a new stake in shares of Aehr Test Systems during the 4th quarter valued at about $272,000. Dimensional Fund Advisors LP boosted its holdings in Aehr Test Systems by 1.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 137,241 shares of the semiconductor company's stock worth $2,283,000 after acquiring an additional 2,365 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in Aehr Test Systems by 23.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 24,716 shares of the semiconductor company's stock worth $412,000 after acquiring an additional 4,772 shares in the last quarter. Northern Trust Corp boosted its holdings in Aehr Test Systems by 8.4% in the fourth quarter. Northern Trust Corp now owns 250,336 shares of the semiconductor company's stock worth $4,163,000 after acquiring an additional 19,401 shares in the last quarter. Finally, Balyasny Asset Management L.P. boosted its holdings in Aehr Test Systems by 82.2% in the fourth quarter. Balyasny Asset Management L.P. now owns 68,714 shares of the semiconductor company's stock worth $1,143,000 after acquiring an additional 30,991 shares in the last quarter. Institutional investors own 69.69% of the company's stock.

Aehr Test Systems Stock Down 0.4%

NASDAQ:AEHR traded down $0.10 on Friday, hitting $26.47. The stock had a trading volume of 1,025,148 shares, compared to its average volume of 1,998,917. The company has a market cap of $793.31 million, a PE ratio of -203.60 and a beta of 2.54. Aehr Test Systems has a 52 week low of $6.27 and a 52 week high of $28.41. The business's fifty day moving average is $20.00 and its 200 day moving average is $13.19.

Aehr Test Systems (NASDAQ:AEHR - Get Free Report) last issued its quarterly earnings data on Tuesday, July 8th. The semiconductor company reported ($0.01) EPS for the quarter, topping the consensus estimate of ($0.02) by $0.01. The firm had revenue of $14.10 million during the quarter, compared to the consensus estimate of $14.83 million. Aehr Test Systems had a negative return on equity of 0.15% and a negative net margin of 6.63%. Equities analysts predict that Aehr Test Systems will post 0.1 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Aehr Test Systems news, VP Alistair N. Sporck sold 3,000 shares of the firm's stock in a transaction on Tuesday, July 15th. The stock was sold at an average price of $14.13, for a total value of $42,390.00. Following the completion of the sale, the vice president directly owned 30,808 shares of the company's stock, valued at $435,317.04. This trade represents a 8.87% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Rhea J. Posedel sold 18,000 shares of the firm's stock in a transaction on Tuesday, July 22nd. The stock was sold at an average price of $19.83, for a total value of $356,940.00. Following the completion of the sale, the director directly owned 71,163 shares of the company's stock, valued at $1,411,162.29. This represents a 20.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 26,000 shares of company stock valued at $506,830 over the last ninety days. 6.20% of the stock is currently owned by insiders.

Aehr Test Systems Profile

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.